Comparison of the perioperative outcomes of laparoscopic and open retroperitoneal lymph node dissection for low-stage (stage I/II) testicular germ cell tumors: a systematic review and meta-analysis

被引:4
|
作者
Ge, Si [1 ]
Gan, Lijian [1 ]
Meng, Chunyang [1 ]
Li, Kangsen [1 ]
Wang, Zuoping [1 ]
Zeng, Zhiqiang [1 ]
Zheng, Lei [1 ]
Li, Yunxiang [1 ,2 ]
机构
[1] North Sichuan Med Coll Univ, Nanchong Cent Hosp, Clin Coll 2, Dept Urol, Nanchong, Sichuan, Peoples R China
[2] North Sichuan Med Coll Univ, Affiliated Nanchong Cent Hosp, Nanchong 637000, Sichuan, Peoples R China
关键词
germ cell tumors; laparoscopy; meta-analysis; retroperitoneal lymph node dissection; testicular cancer; CANCER; GUIDELINES; MANAGEMENT; SAFETY; TRENDS;
D O I
10.1097/JS9.0000000000000321
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective:Comparison of the perioperative outcomes of laparoscopic retroperitoneal lymph node dissection (L-RPLND) and open retroperitoneal lymph node dissection (O-RPLND) for low-stage (stage I/II) testicular germ cell tumors. Methods:The authors performed a systematic review and cumulative meta-analysis of the primary outcomes of interest according to PRISMA criteria, and the quality assessment of the included studies followed the AMSTAR guidelines. Four databases were searched, including Embase, PubMed, the Cochrane Library, and Web of Science. The search period was from the creation of each database to October 2022. The statistical analysis software uses Stata17. Results:There were nine studies involving 579 patients. Compared with O-RPLND, L-RPLND was associated with shorter length of stay [weighted mean difference (WMD)=-3.99, 95% CI: -4.80 to -3.19, P<0.05], less estimated blood loss (WMD=-0.95, 95% CI: -1.35 to -0.54, P<0.05), shorter time to oral intake after surgery (WMD=-0.77, 95% CI: -1.50 to -0.03, P<0.05), and lower overall complications (odds ratio=0.58, 95% CI: 0.38-0.87, P<0.05). Subgroup analysis found that the complication rate of Clavien-Dindo grade II was lower in L-RPLND (odds ratio=0.24, 95% CI: 0.11-0.55, P<0.05). Interestingly, there was no statistically significant difference between the two groups in terms of operation time, lymph node yields, and recurrence rate during follow-up. Conclusion:L-RPLND is superior to O-RPLND and is worthy of clinical promotion.
引用
收藏
页码:995 / 1005
页数:11
相关论文
共 50 条
  • [41] LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION FOR CLINICAL STAGE I NON-SEMINOMATOUS GERM CELL TUMOR
    Hyams, Elias S.
    Pierorazio, Phillip
    Mullins, Jeffrey
    Proteek, Ornab
    Kavoussi, Louis
    Allaf, Mohamad E.
    JOURNAL OF ENDOUROLOGY, 2011, 25 : A165 - A165
  • [43] Retroperitoneal Lymph Node Dissection in Patients with Stage II Seminomatous Germ Cell Tumour
    Oing, Christoph
    Rescigno, Pasquale
    Paffenholz, Pia
    Heinzelbecker, Julia
    Patrikidou, Anna
    Matulewicz, Richard S.
    Huddart, Robert
    EUROPEAN UROLOGY FOCUS, 2024, 10 (03): : 361 - 363
  • [44] Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic Review
    Neuenschwander, Anne
    Lonati, Chiara
    Antonelli, Luca
    Papachristofilou, Alexandros
    Cathomas, Richard
    Rothermundt, Christian
    Templeton, Arnoud J.
    Gulamhusein, Aziz
    Fischer, Stefanie
    Gillessen, Silke
    Hermanns, Thomas
    Lorch, Anja
    Mattei, Agostino
    Fankhauser, Christian D.
    EUROPEAN UROLOGY FOCUS, 2023, 9 (03): : 541 - 546
  • [45] Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003
    Pizzocaro, G.
    Schiavo, M.
    Solima, S.
    Vitellaro, M.
    Biasoni, D.
    Nicolai, N.
    UROLOGIA JOURNAL, 2010, 77 : 50 - 56
  • [46] Primary retroperitoneal lymph node dissection for clinical stage II seminoma: A systematic review and meta-analysis of safety and oncological effectiveness
    Parizi, Mehdi Kardoust
    Margulis, Vitaly
    Bagrodia, Aditya
    Bekku, Kensuke
    Klemm, Jakob
    Matsukawa, Akihiro
    Alimohammadi, Arman
    Motlagh, Reza Sari
    Mostafaei, Hadi
    Laukhtina, Ekaterina
    Shariat, Shahrokh F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (04) : 102 - 109
  • [47] The role of robotic retroperitoneal lymph node dissection in testicular cancer: a systematic review and meta-analysis
    Ge, Si
    Zeng, Zhiqiang
    Li, Yunxiang
    Gan, Lijian
    Meng, Chunyang
    Li, Kangsen
    Wang, Zuoping
    Zheng, Lei
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (09) : 2808 - 2818
  • [48] LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION FOR CLINICAL STAGE I NONSEMINOMATOUS GERM CELL CANCER (NSGCC). ANALYSIS OF 178 CASES
    Rioja Zuazu, J. P.
    Vidal-Moral, I.
    Ramos-Barcelo, E.
    Laguna-Pes, M. P.
    Castillo Cadiz, O. A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 236 - 236
  • [49] Initial Series of Robot-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer
    Williams, Stephen B.
    Lau, Clayton S.
    Josephson, David Y.
    EUROPEAN UROLOGY, 2011, 60 (06) : 1299 - 1302
  • [50] Laparoscopic retroperitoneal lymph node dissection (L-RPLND) as therapeutic in stage I nonseminomatous germ cell testicular tumors: Findings from a referral center.
    Nicolai, Nicola
    Gasperoni, Francesca
    Biasoni, Davide
    Tarabelloni, Nicholas
    Catanzaro, Mario
    Stagni, Silvia
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)